Social determinants and risk factors in tuberculosis surveillance in the EU/EEA
The objective of this report is to provide countries with advice on what social determinant and risk factor variables to collect and what definitions to use, and to propose information to be collected at the national and European level.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
Risk assessment: Situation in northern Africa/Libyan Arab Jamahiriya and the influx of migrants* to Europe
ECDC, after conducting rapid risk assessments, has concluded that the risk of importation of infectious diseases from North Africa to the EU is considered to be low. From a public health perspective, the most urgent concern is related to the poor living conditions of the migrants, such as overcrowding and poor sanitation.
Migrant health: Sexual transmission of HIV within migrant groups in the EU/EEA and implications for effective interventions
This report presents the published evidence of sexual transmission of HIV among populations from countries with generalised HIV epidemics in the EU/EEA.
Thematic Report: Migrants - Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress
Tuberculosis - 85% can save lives
Tuberculosis treatment outcome remains a challenge in the European Union. The European Centre for Disease Prevention and Control highlights that not achieving the treatment success target of 85% could have an impact on human lives saved and the financial resources needed for tuberculosis control in the European Union and beyond.
Joint ECDC and EMCDDA rapid risk assessment: HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania
Most European countries reported no changes in the rate of newly diagnosed cases of HIV or HIV prevalence in IDU in 2011.
Health inequalities, the financial crisis, and infectious disease in Europe
This report summarises the importance of addressing health inequalities by identifying key areas for attention from health professionals and policy makers. Presenting key findings from studies on the subject, it makes the case that socio-economic determinants can have a substantial impact on infectious disease control in Europe.
Review of outbreaks and barriers to MMR vaccination coverage among hard to reach populations in European countries
In recent years, substantial progress had been made towards eliminating measles, mumps and rubella in Europe. Measles vaccine coverage is on the rise and measles cases decreasing in many countries. However, there have still been several large outbreaks of measles, mumps and rubella reported in European countries.